Targeting RET in NSCLC
Podcast | English | 32 Min
Image For Activity Cover
No Credit Offered
The latest episode of Lung Cancer Considered features a conversation between host Dr. Stephen Liu and Dr. Alex Drilon, chief, early drug development at Memorial Sloan Kettering Cancer Center. Together they discuss Dr. Drilon's career and his work on RET fusions in lung cancer.
Dr. Stephen Liu
Dr. Alex Drilon
Powered By